Expression of a prostate associated protein, human glandular kallikrein (hK2), in breast tumours and in normal breast secretions

British Journal of Cancer

Volumn 82, Issue 2, 2000, Pages 361-367

  Black, M H ^a,b   Magklara, A ^a,b   Obiezu, C ^a,b   Levesque, M A ^a,b   Sutherland, D J A ^c   Tindall, D J ^d   Young, C Y F ^d   Sauter, E R ^e   Diamandis, E P ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^d MAYO CLINIC   (United States)

^e FOX CHASE CANCER CENTER   (United States)

Author keywords

Breast cancer; Human glandular kallikrein; Kallikrein gene family; Prostate cancer; Prostate specific antigen

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; PROSTATE SPECIFIC ANTIGEN; STEROID RECEPTOR; TISSUE KALLIKREIN;

ADULT; AGE; AGED; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CONTROLLED STUDY; CORRELATION FUNCTION; CYTOSOL; FEMALE; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; MAJOR CLINICAL STUDY; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROGNOSIS;

EID: 0033978196     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.1999.0927     Document Type: Article

References (33)

1. Black MH, Maglara A, Obiezu C, Melegos DN, Wolfert RL and Diamandis EP (1999) Development of an ultrasensitive immunoassay for human glandular kallikrein (hK2) with no cross reactivity from prostate specific antigen (PSA). Clin Chem 45: 790-799
2. Clements JA, Mukhtar A, Verity K, Pullar M, McNeill P, Cummins J and Fuller PJ (1996) Kallikrein gene expression in human pituitary tissues. Clin Endocrinol 44: 223-231
3. Cohen P, Graves HCB, Peehl DM, Kamarei M, Giudice LC and Rosenfeld RG (1992) Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma. J Clin Endocrinol Metab 75: 1046-1053
4. Corey E, Buhler KR and Vessella RL (1997) Cross-reactivity of ten anti-prostate-specific antigen monoclonal antibodies with human glandular kallikrein. Urology 50: 567-572
5. Cramer SD, Chen Z and Peehl DM (1996) Prostate specific antigen cleaves parathyroid hormone-related protein in the PTH-like domain: inactivation of PTHrP-stimulated cAMP accumulation in mouse osteoblasts. J Urol 156: 526-531
6. Diamandis EP (1996) BRCA1 protein products: antibody specificity, functional motifs and secreted tumour suppressions. Nat Genet 13: 268
7. Diamandis EP and Yu H (1995) New biological functions of prostate specific antigen? J Clin Endocrinol Metab 80: 1515-1517
8. Diamandis EP and Yu H (1997) Nonprostatic sources of prostate-specific antigen. Urol Clin - Am 24: 275-282
9. Diamandis EP, Yu H and Sutherland DJA (1994) Detection of prostate specific antigen immunoreactivity in breast tumors. Breast Cancer Res Treat 32: 301-310
10. Ferguson RA, Yu H, Kalyvas M, Zammit S and Diamandis EP (1996) Ultrasensitive detection of prostate specific antigen by a time-resolved immunofluorometric assay and the Immulite® Immunochemiluminescent third generation assay: potential applications in prostate and breast cancers. Clin Chem 42: 675-684
11. Fichtner J, Graves HCB, Thatcher K, Yemoto C and Shortliffe M (1996) Prostate specific antigen releases a kinin-like substance on proteolysis of seminal vesicle fluid that stimulates smooth muscle contraction. J Urol 155: 738-742
12. Finlay JA, Evans CL, Day JR, Payne JK, Mikolajczyk SD, Millar LS, Kuus-Reichel K, Wolfert RL and Rittenhouse HG (1998) Development of monoclonal antibodies specific for human glandular kallikrein (hK2): development of a dual antibody immunoassay for hK2 with negligible prostate-specific antigen cross-reactivity. Urology 51: 804-809
13. Foretova L, Garber JE, Sadowsky NL, Verselis SJ and Li FP (1996) Prostate-specific antigen in nipple aspirate. Lancet 347: 1631
14. Hsieh M, Charlesworth MC, Goodmanson M, Zhang S, Seay T, Klee GG, Tindall DJ and Young CYF (1997) Expression of human prostate-specific glandular kallikrein protein (hK2) in the breast cancer cell line T47-D. Cancer Res 57: 2651-2656
15. Killian CS, Corral DA, Kawinski E and Constantine RI (1993) Mitogenic response of osteoblast cells to prostate specific antigen suggests an activation of latent TGF-β and a proteolytic modulation of cell adhesion receptors. Biochem Biophys Res Commun 192: 940-947
16. Kumar A, Mikolajczyk SD, Goel AS, Millar LS and Saedi MS (1997) Expression of pro form of prostate-specific antigen by mammalian cells and its conversion to mature, active form by human kallikrein. Cancer Res 57: 3111-3114
17. Lai LC, Erbas H, Lennard TW and Peaston RT (1996) Prostate-specific antigen in breast cyst fluid: possible role of prostate-specific antigen in hormone-dependent breast cancer. Int J Cancer 66: 743-746
18. Lopez-Otin C and Diamandis EP (1998) Breast and prostate cancer: common epidemiologic, genetic and biochemical features. Endocr Rev 19: 365-396
19. Lovgren J, Piironen T, Overmo C, Dowell B, Karp M, Pettersson K, Lilja H and Lundwall A (1995) Production of recombinant PSA and hK2 and analysis of their immunologic cross-reactivity. Biochem Biophys Res Commun 213: 888-895
20. Lovgren J, Rajakoski K, Karp M, Lundwall A and Lilja H (1997) Activation of the zymogen form of prostate-specific antigen by human kallikrein 2. Biochem Biophys Res Commun 238: 549-555
21. McCormack RT, Rittenhouse HG, Finlay JA, Sokoloff RL, Wang TJ, Wolfert RL, Lilja H and Oesterling JE (1995) Molecular forms of prostate-specific antigen and the human kallikrein gene family: a new era. Urology 45: 729-744
22. McGuire WL, Horwitz KB, Pearson OH and Segaloff A (1977) Current status of estrogen and progesterone receptors in breast cancer. Cancer 39: 2934-2947
23. Piironen T, Lovgren J, Karp M, Eerola R, Lundwall A, Dowell B, Lovgren T, Lilja H and Pettersson K (1996) Immunofluorometric assay for sensitive and specific measurement of human prostate glandular kallikrein (hK2) in serum. Clin Chem 42: 1034-1041
24. Riegman PH, Vlietstra RJ, Suurmeijer L, Cleutjens CB and Trapman J (1992) Characterization of the human kallikrein locus. Genomics 14: 6-11
25. Saedi MS, Cass MMJ, Goel AS, Grauer L, Hogen KL, Okaneya T, Griffin BY, Klee GG, Young CY-F and Tindall DJ (1995) Overexpression of a human prostate-specific glandular kallikrein, hK2, in E. coli and generation of antibodies. Mol Cell Endocrinol 109: 237-241
26. Sauter ER, Daly M, Linehan K, Ehya H, Engstrom PF, Bonney G, Ross EA, Yu H and Diamandis EP (1996) Prostate specific antigen levels in nipple aspirate fluid correlate with breast cancer risk. Cancer Epidemiol Biomarkers Prev 5: 967-970
27. Takayama TK, Fujikawa K and Davie EW (1997) Characterization of the precursor of prostate-specific antigen. J Biol Chem 272: 21582-21588
28. Yu H, Diamandis EP, Levesque M, Giai M, Roagna R, Ponzone R, Sismondi P, Monne M and Croce C (1996) Prostate specific antigen in breast cancer, benign breast disease and normal breast tissue. Breast Cancer Res Treat 40: 171-178
29. Yu H, Diamandis EP, Monne M and Croce CM (1995) Oral contraceptive-induced expression of prostate specific antigen in the female breast. J Biol Chem 270: 6615-6618
30. Yu H, Diamandis EP and Sutherland DJA (1994) Immunoreactive prostate specific antigen levels in female and male breast tumours and its association with steroid hormone receptors and patient age. Clin Biochem 27: 75-79
31. Yu H, Giai M, Diamandis EP, Katsaros D, Sutherland DJA, Levesque MA, Roagna R, Ponzone R and Sismondi P (1995) Prostate specific antigen is a new favorable prognostic indicator for women with breast cancer. Cancer Res 55: 2104-2110
32. Yu H, Levesque MA, Clark GM and Diamandis EP (1998) Prognostic value of prostate-specific antigen for women with breast cancer: a large U.S. cohort study. Clin Cancer Res 4: 1489-1497
33. Zarghami N, Grass L and Diamandis EP (1997) Steroid hormone regulation of prostate specific antigen gene expression in breast cancer. Br J Cancer 75: 579-588